| Artificial intelligence in nanomedicine D Ho, P Wang, T Kee Nanoscale Horizons 4 (2), 365-377, 2019 | 106 | 2019 |
| Modulating BET Bromodomain Inhibitor ZEN-3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform AJ Pantuck, DK Lee, T Kee, P Wang, S Lakhotia, MH Silverman, C Mathis, ... Advanced Therapeutics 1 (6), 1800104, 2018 | 95 | 2018 |
| Harnessing CURATE. AI as a Digital Therapeutics Platform by Identifying N‐of‐1 Learning Trajectory Profiles T Kee, C Weiyan, A Blasiak, P Wang, JK Chong, J Chen, BTT Yeo, D Ho, ... Advanced Therapeutics 2 (9), 1900023, 2019 | 33 | 2019 |
| The IDentif. AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens A Blasiak, ATL Truong, A Remus, L Hooi, SGK Seah, P Wang, DH Chye, ... NPJ Digital Medicine 5 (1), 83, 2022 | 22 | 2022 |
| Control of nanodiamond-doxorubicin drug loading and elution through optimized compositions and release environments P Wang, W Su, X Ding Diamond and Related Materials 88, 43-50, 2018 | 14 | 2018 |
| The role of artificial intelligence in scaling nanomedicine toward broad clinical impact J Khong, P Wang, TRX Gan, J Ng, TTL Anh, A Blasiak, T Kee, D Ho Nanoparticles for Biomedical Applications, 385-407, 2020 | 11 | 2020 |
| N-of-1 healthcare: challenges and prospects for the future of personalized medicine K You, P Wang, D Ho Frontiers in Digital Health 4, 830656, 2022 | 7 | 2022 |
| IDentif. AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 Intervention A Blasiak, ATL Truong, P Wang, L Hooi, DH Chye, SB Tan, K You, ... ACS nano 16 (9), 15141-15154, 2022 | 6 | 2022 |
| Artificial Intelligence: Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE. AI, an … AJ Pantuck, DK Lee, T Kee, P Wang, S Lakhotia, MH Silverman, C Mathis, ... Advanced Therapeutics 1 (6), 1870020, 2018 | 6 | 2018 |
| Addressing antimicrobial resistance with the IDentif. AI platform: Rapidly optimizing clinically actionable combination therapy regimens against nontuberculous mycobacteria D Mukherjee, P Wang, L Hooi, V Sandhu, K You, A Blasiak, EKH Chow, ... Theranostics 12 (16), 6848, 2022 | 5 | 2022 |
| Synthesis and characterization of nanodiamond–growth factor complexes toward applications in oral implantation and regenerative medicine JYR Bang, C Ting, P Wang, T Kim, KK Wang, T Kee, D Miya, D Ho, ... Journal of Oral Implantology 44 (3), 207-211, 2018 | 5 | 2018 |
| Defining the optimal time to appendectomy: A step toward precision surgery T Kabir, NL Syn, V Shaw, YHA Tan, HW Chua, LWL Ong, FH Koh, ... Surgery 172 (3), 798-806, 2022 | 3 | 2022 |
| The role of artificial intelligence in scaling nanomedicine toward broad clinical impact. Nanoparticles for Biomedical Applications Fundamental Concepts, Biological Interactio … J Khong, P Wang, TR Gan Elsevier, Amsterdam, 2019 | 3 | 2019 |
| Deep learning and drug discovery for healthy aging P Wang, D Ho ACS Central Science 9 (10), 1860-1863, 2023 | 2 | 2023 |
| WisDM Green: Harnessing artificial intelligence to design and prioritize compound combinations in peat moss for sustainable farming applications P Wang, K You, YH Ong, JN Yeoh, JPQ Ong, ATL Truong, A Blasiak, ... Advanced Intelligent Systems 4 (10), 2200095, 2022 | 2 | 2022 |
| N-of-1 medicine P Wang, QY Leong, NY Lau, WY Ng, SP Kwek, L Tan, SW Song, K You, ... Singapore Medical Journal 65 (3), 167-175, 2024 | 1 | 2024 |
| Discovery of Broad‐Spectrum Repurposed Drug Combinations Against Carbapenem‐Resistant Enterobacteriaceae (CRE) Through Artificial Intelligence (AI … M Li, K You, P Wang, L Hooi, Y Chen, A Siah, SB Tan, J Teo, OT Ng, ... Advanced Therapeutics, 2300332, 2024 | 1 | 2024 |
| CURATE. AI Digital Therapeutics: Harnessing CURATE. AI as a Digital Therapeutics Platform by Identifying N‐of‐1 Learning Trajectory Profiles (Adv. Therap. 9/2019) T Kee, C Weiyan, A Blasiak, P Wang, JK Chong, J Chen, BTT Yeo, D Ho, ... Advanced Therapeutics 2 (9), 1970019, 2019 | 1 | 2019 |
| CURATE. AI: Personalized Liver Transplant Tacrolimus Dosing. A Zarrinpar, T Kee, P Wang, J Khong, U Kim, J Chong, JB Jeong, ... AMERICAN JOURNAL OF TRANSPLANTATION 19, 1111-1111, 2019 | 1 | 2019 |
| Radiation therapy with phenotypic medicine: towards N-of-1 personalization LM Chong, P Wang, VV Lee, S Vijayakumar, HQ Tan, FQ Wang, ... British Journal of Cancer, 1-10, 2024 | | 2024 |
